Are Antivirals For COVID-19 More Likely to Be Developed and Approved Before a Vaccine

Nachrichtenquelle: PR Newswire (engl.)
18.06.2020, 14:30  |  398   |   |   

Financialnewsmedia.com News Commentary

PALM BEACH, Florida, June 18, 2020 /PRNewswire/ -- Now that confirmed worldwide cases of the global health crisis are continuing to grow, scientists are pushing forward with efforts to develop vaccines and treatments to slow the pandemic and lessen the disease's damage. Scientists around the world are working on potential treatments and vaccines and several companies are working on antiviral drugs, some of which are already in use against other illnesses, to treat people who already have COVID-19. Other companies are working on vaccines that could be used as a preventive measure against the disease. Some of the earliest treatments will likely be drugs that are already approved for other conditions, or have been tested on other viruses. An article in Healthline.com said: "People are looking into whether existing antivirals might work or whether new drugs could be developed to try to tackle the virus," said Dr. Bruce Y. Lee,  a professor at the CUNY Graduate School of Public Health & Health Policy. These drugs are still being tested in clinical trials to see if they are effective against COVID-19. This step is needed to make sure the medications are safe for this particular use and what the proper dosage should be. So it could be months before treatments are available that are known to work against COVID-19. It could be even longer for a vaccine.   Active healthcare stocks in news today include:  BioSig Technologies, Inc. (NASDAQ: BSGM), Moderna, Inc. (NASDAQ: MRNA), Novavax, Inc. (NASDAQ:NVAX), Johnson & Johnson (NYSE: JNJ), AstraZeneca PLC (NYSE: AZN).

But there are still other tools we can use to reduce the damage done by the novel coronavirus.  "Even though technological advances allow us to do certain things more quickly," Lee told Healthline, "we still have to rely on social distancing, contact tracing, self-isolation, and other measures."  The article continued, saying that: "It can take a decade or more for a new compound to go from initial discovery to the marketplace. Many compounds never even make it that far. That's why many medications being eyed as potential treatments for COVID-19 are drugs that already exist. In a recent review in the British Journal of Pharmacology, scientists from the United Kingdom called for wider screening of existing drugs to see if they might work against the coronavirus.

Seite 1 von 5
Novavax Aktie jetzt ab 0€ handeln - auf Smartbroker.de

Diesen Artikel teilen

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel